Ixchelsis in the news, articles in BioCentury and Fierce Biotech

Ixchelsis: Lasting longer

Ixchelsis Ltd.’s oxytocin receptor antagonist could help treat premature ejaculation more safely than antidepressant SSRIs, which are prescribed off label for the condition. Premature ejaculation is one of the most common male sexual dysfunctions and affects 20-30% of … >> Full BioCentury article here (page A13)


U.K. biotech startup forges close ties to Eli Lilly’s R&D experts

Even the smallest biotech company can benefit when it thinks–and acts–globally. And a biotech startup that was able to grab a promising therapeutic asset from Pfizer ($PFE) as it shuttered much of its work in the U.K. has pieced together a global virtual organization that illustrates just how effective … >> Full FierceBiotech article here